Dr. Eric Larsen Discusses Outcomes for AYA Patients With Acute Lymphoblastic Leukemia
49 Views
administrator
08/04/23
Eric Larsen, MD, medical director of the Maine Children's Cancer Program, discusses a large phase III study that compared outcomes between adolescent and young adult (AYA) and younger patients with high-risk acute lymphoblastic leukemia (HR-ALL).
Find out more at http://www.onclive.com/onclive....-tv/Dr-Larsen-Discus
-
Category
Show more
Facebook Comments
No comments found